VICP — Vicapsys Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00
- $19.88m
- $20.14m
- 12
- 49
- 11
- 14
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -1.03 | -0.766 | -0.237 | -0.985 |
Amortisation | ||||
Non-Cash Items | -0.014 | 0.015 | -0.096 | 0.446 |
Discontinued Operations | ||||
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.047 | 0.457 | -0.143 | 0.269 |
Change in Prepaid Expenses | ||||
Change in Accounts Payable | ||||
Change in Accrued Expenses | ||||
Cash from Operating Activities | -0.97 | -0.263 | -0.444 | -0.238 |
Other Investing Cash Flow Items | — | — | 0.1 | 0 |
Sale/Maturity of Investment | ||||
Cash from Investing Activities | — | — | 0.1 | 0 |
Financing Cash Flow Items | 0.177 | 0 | — | -0.015 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Cash from Financing Activities | 1.15 | 0 | 0.56 | 0.035 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.178 | -0.263 | 0.216 | -0.203 |